← Eichor
Condition: Central Nervous System Cns Metastases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Central Nervous System Cns Metastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Phase 3 · 4 location(s) · Mayo Clinic · NCT03750227Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section
NA · 1 location(s) · Nigde Omer Halisdemir University · NCT07440667Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
NA · 2 location(s) · Hebrew SeniorLife · NCT06821568Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis
Phase 4 · 1 location(s) · Fudan University · NCT06230055Swiss Spinal Tumor Registry (Swiss-STR)
Phase N/A · 1 location(s) · Luzerner Kantonsspital · NCT06869746Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Phase 2 · 3 location(s) · Wake Forest University Health Sciences · NCT02422641Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Canc
Phase 1/Phase 2 · 1 location(s) · Guangzhou Medical University · NCT06462092A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05184816Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
Phase N/A · 3 location(s) · University of Zurich · NCT06417710Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Techni
Phase 2 · 2 location(s) · Medical College of Wisconsin · NCT05045950Treating Chronic Cervicogenic Head and Neck Pain
Phase 1/Phase 2 · 1 location(s) · Michigan State University · NCT05617365Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and A
Phase 2 · 1 location(s) · University of Rochester · NCT04965064Efficacy and Central Mechanisms of Electroacupuncture for Medication Overuse Headache
NA · 1 location(s) · Guang'anmen Hospital of China Academy of Chinese Medical Sci · NCT06802471Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy.
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07632092Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05026983Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
Phase 1/Phase 2 · 2 location(s) · Samsung Medical Center · NCT06552559Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Phase 2 · 1 location(s) · Tiziana Life Sciences LTD · NCT06890923Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
Phase 1/Phase 2 · 2 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT04923542Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects
NA · 1 location(s) · Children's National Research Institute · NCT06036199High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases
Phase 2 · 1 location(s) · Hunan Province Tumor Hospital · NCT05379803The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Br
NA · 1 location(s) · University Hospital Heidelberg · NCT05378633Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Phase 1/Phase 2 · 86 location(s) · Stemline Therapeutics, Inc. · NCT05386108Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Phase 1 · 1 location(s) · Plus Therapeutics · NCT07098806REMASTer: REcurrent Brain Metastases After SRS Trial
NA · 9 location(s) · Monteris Medical · NCT05124912Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07462507Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Phase 3 · 51 location(s) · Mercy Health Ohio · NCT05611242A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function De
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT02504788A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07137494A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatmen
Phase 2 · 1 location(s) · Shanghai Cancer Hospital, China · NCT06901817Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis
Phase 1/Phase 2 · 1 location(s) · Guangzhou Medical University · NCT06809517
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.